- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/56 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Patent holdings for IPC class C07K 7/56
Total number of patents in this class: 541
10-year publication summary
|
35
|
37
|
37
|
36
|
33
|
35
|
24
|
31
|
41
|
30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4845 |
48 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 67 |
38 |
| Palatin Technologies, Inc. | 68 |
14 |
| Protagonist Therapeutics, Inc. | 140 |
11 |
| Aileron Therapeutics, Inc. | 80 |
10 |
| Zealand Pharma A/S | 258 |
9 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
8 |
| Polyphor Ltd. | 19 |
8 |
| Provincial Health Services Authority | 187 |
8 |
| President and Fellows of Harvard College | 6013 |
7 |
| NovoBiotic Pharmaceuticals, LLC | 22 |
7 |
| The University of Tokyo | 4235 |
7 |
| Xellia Pharmaceuticals ApS | 93 |
7 |
| Bicyclerd Limited | 147 |
7 |
| The University of British Columbia | 1521 |
6 |
| Novartis AG | 10686 |
5 |
| The Regents of the University of California | 20172 |
5 |
| The Texas a & M University System | 1752 |
5 |
| Universitaet Zuerich | 34 |
5 |
| University of Utah Research Foundation | 1829 |
5 |
| Other owners | 321 |